Literature DB >> 17823955

The immunocompetence of Schwann cells.

Gerd Meyer zu Hörste1, Wei Hu, Hans-Peter Hartung, Helmar C Lehmann, Bernd C Kieseier.   

Abstract

Schwann cells are the myelinating glial cells of the peripheral nervous system that support and ensheath axons with myelin to enable rapid saltatory signal propagation in the axon. Immunocompetence, however, has only recently been recognized as an important feature of Schwann cells. An autoimmune response against components of the peripheral nervous system triggers disabling inflammatory neuropathies in patients and corresponding animal models. The immune system participates in nerve damage and disease manifestation even in non-inflammatory hereditary neuropathies. A growing body of evidence suggests that Schwann cells may modulate local immune responses by recognizing and presenting antigens and may also influence and terminate nerve inflammation by secreting cytokines. This review summarizes current knowledge on the interaction of Schwann cells with the immune system, which is involved in diseases of the peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17823955     DOI: 10.1002/mus.20893

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  27 in total

Review 1.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

2.  Plasticity of Schwann cells and pericytes in response to islet injury in mice.

Authors:  Shiue-Cheng Tang; Yu-Chen Chiu; Chia-Tung Hsu; Shih-Jung Peng; Ya-Yuan Fu
Journal:  Diabetologia       Date:  2013-06-26       Impact factor: 10.122

3.  GSK3β inhibition accelerates axon debris clearance and new axon remyelination.

Authors:  Yixun Chen; Jian Weng; Duanyang Han; Bo Chen; Mingtai Ma; Youlai Yu; Ming Li; Zhongdi Liu; Peixun Zhang; Baoguo Jiang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 4.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

Review 5.  [The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].

Authors:  M Stangel; H-P Hartung; R Gold; B C Kieseier
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

6.  Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies.

Authors:  Gerd Meyer Zu Horste; Holger Heidenreich; Helmar C Lehmann; Soldano Ferrone; Hans-Peter Hartung; Heinz Wiendl; Bernd C Kieseier
Journal:  Glia       Date:  2010-01-01       Impact factor: 7.452

7.  Immunodominant fragments of myelin basic protein initiate T cell-dependent pain.

Authors:  Huaqing Liu; Sergey A Shiryaev; Andrei V Chernov; Youngsoon Kim; Igor Shubayev; Albert G Remacle; Svetlana Baranovskaya; Vladislav S Golubkov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Neuroinflammation       Date:  2012-06-07       Impact factor: 8.322

8.  Self-assembling multidomain peptide hydrogels accelerate peripheral nerve regeneration after crush injury.

Authors:  Tania L Lopez-Silva; Carlo D Cristobal; Cheuk Sun Edwin Lai; Viridiana Leyva-Aranda; Hyun Kyoung Lee; Jeffrey D Hartgerink
Journal:  Biomaterials       Date:  2020-09-19       Impact factor: 12.479

9.  The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.

Authors:  João Moreira; Susete Costelha; Margarida Saraiva; Maria João Saraiva
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

10.  Allografts of the acellular sciatic nerve and brain-derived neurotrophic factor repair spinal cord injury in adult rats.

Authors:  Changyu Li; Xiangtong Zhang; Ronglong Cao; Bohai Yu; Hongsheng Liang; Min Zhou; Dayong Li; Yuehua Wang; Enzhong Liu
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.